Hememics Biotechnologies, Inc

Hememics uniquely uses graphene-based sensors with our patented bio preservatives to bring handheld, lab-quality testing performance to wherever needed whether it is a farm, emergency room or battlefield. Our rugged, low-cost platform consists of a portable, easy-to-use reader utilizing a single-use biochip with 32 sensors. Our sensors can be individually programmed to detect molecular, antigen and antibody targets. We put a whole lab in your hand so you can make decisions when and wherever necessary simplifying workflows with results within minutes

Biotechnology,healthcare,graphene biosensor,and point of care

Hememics biotechnologies, inc operates in the Biotechnology research industry.

Hememics biotechnologies, inc's revenue is 11m - 100m

Hememics biotechnologies, inc has 11 - 50 employees.